Brief: XOMA Earns $9 Million Milestone As FDA Grants Accelerated Approval To Day One’s OJEMDATM

Xoma Royalty

25/04/2024 12:53

April 25 (Reuters) - XOMA Corp  XOMA.O :
    * XOMA EARNS $9 MILLION MILESTONE AS FDA GRANTS ACCELERATED
APPROVAL TO DAY ONE’S OJEMDATM (TOVORAFENIB) FOR RELAPSED OR
REFRACTORY BRAF-ALTERED PEDIATRIC LOW-GRADE GLIOMA (PLGG)

Source text for Eikon:  ID:nGNXPLNkJ 
Further company coverage:  XOMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))